✦ LIBER ✦

Young-onset Parkinson's disease: A clinical pathologic description of two siblings

✍ Scribed by Rowena Emilia J. Tabamo; Hubert H. Fernandez; Joseph H. Friedman; David K. Simon

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 572 KB
Volume: 15
Category: Article
ISSN: 0885-3185
DOI: 10.1002/1531-8257(200007)15:4<744::aid-mds1026>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Laryngeal dystonia as a presenting sympt

Laryngeal dystonia as a presenting symptom of young-onset Parkinson's disease

✍ Spiridon Papapetropoulos; Donna S. Lundy; Roy R. Casiano; Carlos Singer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 1 views

Echocardiogram revealed diffuse hypokinesis, dilatation of left ventricular cavity, and thinning of left ventricular wall. Ejection fraction was decreased to 49%. Cardiac muscle biopsy demonstrated hypertrophied cardiomyocyte and interstitial fibrosis of left ventricle. A gastrocnemius muscle biopsy

Paroxysmal exercise-induced dystonia as

Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease

✍ Maria Bozi; Kailash P. Bhatia 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

## Abstract Paroxysmal exercise‐induced dystonia (PED) is a rare, typically idiopathic familial condition, although sporadic and secondary cases have been reported. We present 2 cases where PED was the presenting feature of young‐onset idiopathic Parkinson's disease (PD), preceding the onset of par

Cardiac sympathetic denervation correlat

Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease

✍ Hiroshige Fujishiro; Roberta Frigerio; Melinda Burnett; Kevin J. Klos; Keith A. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract Attention has been drawn to cardiac sympathetic denervation in Parkinson's disease (PD) based on clinical studies using [123I] metaiodobenzylguanidine scintigraphy; however, the histologic correlates and time course of cardiac sympathetic denervation are poorly understood. To address th

A comparison of treatment thresholds in

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts

✍ Connie Marras; Anthony E. Lang; Shirley W. Eberly; David Oakes; Stanley Fahn; St 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Abstract Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) and Parkinson Research Examination of CEP‐1347 Trial (PRECEPT) were two clinical trials of potential disease‐modifying agents for Parkinson's disease that used the time to reaching disability sufficient to require d

Quantitative description of loss of clin

Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease

✍ Robert A. Hauser; Nicholas H.G. Holford 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

## Abstract In Parkinson's disease, effects of medications on the progression of the underlying disease can be assessed clinically by evaluating patients at baseline prior to treatment and at endpoint following medication washout. With this design, it is critical to employ a washout of sufficient d

Familial Parkinsonism and early onset Pa

Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations

✍ Sarah Teixeira Camargos; Leonardo Oliveira Dornas; Parastoo Momeni; Andrew Lees; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract The aim of the study was to evaluate the frequency and to perform phenotypic and genotypic characterization of familial Parkinsonism and early onset Parkinson's disease (EOPD) in a Brazilian movement disorder unit. We performed a standardized clinical assessment of patients followed by